DUBLIN, Jan. 21, 2015 /PRNewswire/ --
Research and Markets(http://www.researchandmarkets.com/research/c25bz3/infectious) has announced the addition of the "Infectious Disease Testing Market in the US 2015-2019" report to their offering.
This comprehensive report predicts that the US infectious disease testing market will grow with a CAGR of 5.81% during the 2014-2019 period.
The author's report, Infectious Disease Testing Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the five key vendors in the market. The vendor landscape focuses on vendors that provide access to new technologies. The report also outlines the challenges faced by vendors and the market at large, as well as the key trends emerging in the market.
Key Topics Covered:
The market is segmented based on technology
- Molecular diagnostic test
- Immunodiagnostic test
The POCT for infectious disease is further segmented based on application
- Sexual health
- Tropical diseases
In addition, the market is segmented based on products
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- Abbott Diagnostics
- Beckman Coulter Diagnostics
- Siemens Healthcare
- Acon Laboratories
- Bio-Rad Laboratories
- Chembio Diagnostic Systems
- Clarity Diagnostics
- EMD Millipore
- Epitope Diagnostic
- Gold Standard Diagnostics
- InBios International
- Life Technologies
- Maxim Biomedical
- OraSure Technologies
- Ortho Clinical Diagnostics
- Quidel Corporation
- Thermo Fisher Scientific
- Trinity Biotech
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by application
PART 07: Geographical segmentation
PART 08: Market drivers
PART 09: Impact of drivers
PART 10: Market challenges
PART 11: Impact of drivers and challenges
PART 12: Market trends
PART 13: Vendor landscape
PART 14: Key vendor analysis
PART 15: Key recommendations for vendors/investors
PART 16: Appendix
For more information visit http://www.researchandmarkets.com/research/c25bz3/infectious
Media Contact: Laura Wood , +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets